Botanical species · safety record

Asarum canadense

The EFSA Compendium of Botanicals holds 9 constituent measurements for Asarum canadense. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Asarum canadense L.

9Constituent measurements
0Safety records
3Cited sources
2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Asarum canadense as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Root

What the records describe

Constituents measured

  • Elemicin3
  • Methyleugenol2
  • (e)-isoelemicin1
  • Aristolochia1
  • Methylisoeugenol1
  • Myristicin1

Plant parts

  • Roots and other underground parts9

Preparations

  • Essential oil8
  • Solvent extraction1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
ElemicinRoots and other underground partsEssential oil1.76 PercentGC-MSResolve DOI
MethyleugenolRoots and other underground partsEssential oil36.05 PercentGC-MSResolve DOI
(e)-isoelemicinRoots and other underground partsEssential oil20 PercentGaschromatography (GC)No resolvable identifier
AristolochiaRoots and other underground partsSolvent extraction0.037 PercentHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
ElemicinRoots and other underground partsEssential oil≥ 1.6 PercentGaschromatography (GC)No resolvable identifier
ElemicinRoots and other underground partsEssential oil≤ 4.9 PercentGaschromatography (GC)No resolvable identifier
MethyleugenolRoots and other underground partsEssential oil53.8 PercentGaschromatography (GC)No resolvable identifier
MethylisoeugenolRoots and other underground partsEssential oil1.1 PercentGaschromatography (GC)No resolvable identifier
MyristicinRoots and other underground partsEssential oil2.2 PercentGaschromatography (GC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Belanger, Andre., Collin, Guy., Garneau, Francois-Xavier., Gagnon, Helene., Pichette, Andre. Aromas From Quebec. II. Composition of the Essential Oil of the Rhizomes and Roots of Asarum canadense L. . Journal of essential oil research, 2010, vol. 22, no. 2, p. 164-169.
  2. Schaneberg, BT., Applequist, WL., Khan, IA. Determination of aristolochic acid I and II in North American species of Asarum and Aristolochia . Pharmazie, 2002, vol. 57, no. 10, p. 686-689.
  3. MOTTO, MG., SECORD, NJ. COMPOSITION OF THE ESSENTIAL OIL FROM ASARUM-CANADENSE. Journal of agricultural and food chemistry, 1985, vol. 33, no. 5, p. 789-791. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue